Kameyama S, Yamauchi K, Yasuda S, Kondo S
Jpn J Med Sci Biol. 1980 Apr;33(2):67-80. doi: 10.7883/yoken1952.33.67.
Hemagglutination (HA) and toxin neutralization (TN) tests were used to titrate human and guinea-pig serum specimens taken at various stages of immunization for diphtheria antitoxin. The ratio of HA to TN titers varied significantly depending on the immune status. The ratios and the range of their variations became larger and high values exceeding five were often obtained after repeated booster immunization. Such a high value was proved to be related to the antibody against fragment A (FrA) of diphtheria toxin, since the ratio reduced significantly when anti-FrA was absorbed. Anti-FrA was not produced in children after the basic immunization with diphtheria toxoid and was detected in only one-third of vaccines after the booster injection given after 1 year. It was produced abundantly, however, when booster immunization was repeated. The pattern of production of anti-FrA in guinea pigs was similar to that in humans, when immunized with diphtheria toxoid with adjuvant. No anti-FrA was produced even when the animals were immunized repeatedly with plain diphtheria toxoid.
采用血凝试验(HA)和毒素中和试验(TN)对在白喉抗毒素免疫不同阶段采集的人及豚鼠血清标本进行滴定。HA与TN滴度之比因免疫状态不同而有显著差异。该比值及其变化范围在重复加强免疫后变得更大,且常获得超过5的高值。已证明如此高的值与抗白喉毒素A片段(FrA)抗体有关,因为当抗FrA被吸收时,该比值显著降低。儿童在白喉类毒素基础免疫后不产生抗FrA,在1年后进行加强注射后,仅三分之一的接种者中检测到抗FrA。然而,当重复进行加强免疫时,抗FrA会大量产生。当用佐剂白喉类毒素免疫时,豚鼠体内抗FrA的产生模式与人类相似。即使动物反复用纯白喉类毒素免疫,也不会产生抗FrA。